Degradation and epimerization of ergot alkaloids after baking and in vitro digestion

被引:0
作者
Stefan Merkel
Baha Dib
Ronald Maul
Robert Köppen
Matthias Koch
Irene Nehls
机构
[1] Federal Institute for Materials Research and Testing,Department of Biology, Chemistry and Pharmacy
[2] Freie Universität Berlin,undefined
来源
Analytical and Bioanalytical Chemistry | 2012年 / 404卷
关键词
HPLC-FLD; Rye; Ergotoxine; Ergotamine;
D O I
暂无
中图分类号
学科分类号
摘要
The degradation and epimerization of ergot alkaloids (EAs) in rye flour were investigated after baking cookies and subsequently subjecting them to an in vitro digestion model. Different steps of digestion were analyzed using salivary, gastric, and duodenal juices. The degradation and bidirectional conversion of the toxicologically relevant (R)-epimers and the biologically inactive (S)-epimers for seven pairs of EAs were determined by a HPLC method coupled with fluorescence detection. Baking cookies resulted in degradation of EAs (2–30 %) and a shift in the epimeric ratio toward the (S)-epimer for all EAs. The applied digestion model led to a selective toxification of ergotamine and ergosine, two ergotamine-type EAs. The initial percentage of the toxic (R)-epimer in relation to the total toxin content was considerably increased after digestion of cookies. Ergotamine and ergosine increased from 32 to 51 % and 35 to 55 %, respectively. In contrast, EAs of the ergotoxine type (ergocornine, α- and β-ergocryptine, and ergocristine) showed an epimeric shift toward their biologically inactive (S)-epimers. Further experiments indicated that the selective epimerization of ergotamine EAs occurs in the duodenal juice only. These results demonstrate that toxification of EAs in the intestinal tract should be taken into consideration.
引用
收藏
页码:2489 / 2497
页数:8
相关论文
共 90 条
[1]  
Lee MR(2009)undefined J R Coll Edinb 39 179-184
[2]  
Haarmann T(2009)undefined Mol Plant Pathol 10 563-577
[3]  
Rolke Y(2002)undefined Lancet 359 1768-1770
[4]  
Giesbert S(1945)undefined Helv Chim Acta 28 1283-1308
[5]  
Tudzynski P(1982)undefined J Med Chem 25 937-942
[6]  
De Costa C(1988)undefined Eur J Pharmacol 158 79-84
[7]  
Stoll A(2001)undefined Pharm Chem J 35 37-45
[8]  
Pierri L(2008)undefined Anal Bioanal Chem 391 563-576
[9]  
Pitman IH(2008)undefined World Mycotoxin J 1 67-78
[10]  
Rae ID(2002)undefined J Anim Sci 80 1616-1622